An increase in the Omega-6/Omega-3 fatty acid ratio increases the risk for obesity

Nutrients

Volumn 8, Issue 3, 2016, Pages

  Simopoulos, Artemis P ^a  

^a Center for Nutrition Genetics & Health   (United States)

Author keywords

Browning of adipose tissue; Eicosanoids; Endocannabinoids; FTO (Fat Mass and Obesity Associated) Gene; Obesity; Omega 6 and omega 3 essential fatty acids; Omega 6 and omega 3 fatty acid ratio

Indexed keywords

ADIPOPHILIN; ARACHIDONIC ACID; CANNABINOID; DIHOMO GAMMA LINOLENIC ACID; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ENDOCANNABINOID; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 1; LINOLENIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL;

ADIPOCYTE; ADIPOGENESIS; BODY COMPOSITION; DIET SUPPLEMENTATION; FAT INTAKE; FAT MASS; FATTY ACID SYNTHESIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; INFLAMMATION; LIPID ANALYSIS; LIPID COMPOSITION; NONHUMAN; OBESITY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SKINFOLD THICKNESS; ADIPOSE TISSUE; ADVERSE EFFECTS; ANIMAL; DIET; DIETARY SUPPLEMENT; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHENOTYPE; RISK FACTOR;

ADIPOSE TISSUE; ADIPOSITY; ANIMALS; DIET; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OBESITY; PHENOTYPE; RISK ASSESSMENT; RISK FACTORS;

EID: 84960126712     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8030128     Document Type: Review

References (108)

1. Simopoulos, A.P. Evolutionary aspects of diet and essential fatty acids. In Fatty Acids and Lipids—New Findings; Hamazaki, T., Okuyama, H., Eds.; Karger: Basel, Switzerland, 2001; Volume 88, pp. 18–27.
2. Kang, J.X. The importance of omega-6/omega-3 fatty acid ratio in cell function. The gene transfer of omega-3 fatty acid desaturase. In Omega-6/Omega-3 Essential Fatty Acid Ratio: The Scientific Evidence; Simopoulos, A.P., Cleland, L.G., Eds.; Karger: Basel, Switzerland, 2003; Volume 92, pp. 23–36.
3. Simopoulos, A.P. The importance of the omega-6/omega-3 Fatty Acid ratio in cardiovascular disease and other chronic diseases. Exp. Biol. Med. 2008, 233, 674–688.
4. Simopoulos, A.P. Dietary Omega-3 Fatty Acid Deficiency and High Fructose Intake in the Development of Metabolic Syndrome, Brain Metabolic Abnormalities, and Non-Alcoholic Fatty Liver Disease. Nutrients 2013, 5, 2901–2923.
5. Donahue, S.M.; Rifas-Shiman, S.L.; Gold, D.R.; Jouni, Z.E.; Gillman, M.W.; Oken, E. Prenatal fatty acid status and child adiposity at age 3 years: Results from a US pregnancy cohort. Am. J. Clin. Nutr. 2011, 93, 780–788.
6. Kromhout, D.; de Goede, J. Update on cardiometabolic health effects of ω-3 fatty acids. Curr. Opin. Lipidol. 2014, 25, 85–90.
7. Kromann, N.; Green, A. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950–1974. Acta Med. Scand. 1980, 208, 401–406.
8. Adler, A.I.; Boyko, E.J.; Schraer, C.D.; Murphy, N.J. Lower prevalence of impaired glucose tolerance and diabetes associated with daily seal oil or salmon consumption among Alaska Natives. Diabetes Care 1994, 17, 1498–1501.
9. Schraer, C.D.; Risica, P.M.; Ebbesson, S.O.; Go, O.T.; Howard, B.V.; Mayer, A.M. Low fasting insulin levels in Eskimos compared to American Indians: are Eskimos less insulin resistant? Int. J. Circumpolar Health 1999, 58, 272–280.
10. Nettleton, J.A.; Katz, R. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: A review. J. Am. Diet. Assoc.2005, 105, 428–440.
11. Mozaffarian, D.; Rimm, E.B. Fish intake, contaminants, and human health: Evaluating the risks and the benefits.JAMA 2006, 296, 1885–1899.
12. Birch, E.E.; Hoffman, D.R.; Castañeda, Y.S.; Fawcett, S.L.; Birch, D.G.; Uauy, R.D. A randomized controlled trial of long-chain polyunsaturated fatty acid supplementation of formula in term infants after weaning at 6 wk of age. Am. J. Clin. Nutr. 2002, 75, 570–580.
13. Guesnet, P.; Pugo-Gunsam, P.; Maurage, C.; Pinault, M.; Giraudeau, B.; Alessandri, J.M.; Durand, G.; Antoine, J.M.; Couet, C. Blood lipid concenttrations of docosahexaenoic and arachidonic acids at birth determine their relative postnatal changes in term infants fed breast milk or formula. Am. J. Clin. Nutr. 1999, 70, 292–298.
14. Couet, C.; Delarue, J.; Ritz, P.; Antoine, J.M.; Lamisse, F. Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. Int. J. Obes. Relat. Metab. Disord. 1997, 21, 637–643.
15. Fontani, G.; Corradeschi, F.; Felici, A.; Alfatti, F.; Bugarini, R.; Fiaschi, A.I.; Cerretani, D.; Montorfano, G.; Rizzo, A.M.; Berra, B. Blood profiles, body fat and mood state in healthy subjects on different diets supplemented with omega-3 polyunsaturated fatty acids. Eur. J. Clin. Investig. 2005, 35, 499–507.
16. Hill, A.M.; Buckley, J.D.; Murphy, K.J.; Howe, P.R. Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors. Am. J. Clin. Nutr. 2007, 85, 1267–1274.
17. Belury, M.A.; Mahon, A.; Banni, S. The conjugated linoleic acid (CLA) isomer, t10c12-CLA, is inversely associated with changes in body weight and serum leptin in subjects with type 2 diabetes mellitus. J. Nutr. 2003, 133, 257S–260S.
18. Chan, D.C.; Watts, G.F.; Nguyen, M.N.; Barrett, P.H. Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesity. Am. J. Clin. Nutr. 2006, 84, 37–43.
19. Simopoulos, A.P. The Impact of the Bellagio Report on Healthy Agriculture, Healthy Nutrition, Healthy People: Scientific and Policy Aspects and the International Network of Centers for Genetics, Nutrition and Fitness for Health.J. Nutrigenet. Nutrigenom. 2015, 7, 189–209.
20. Simopoulos, A.P. ω-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr. 1991, 54, 438–463.
21. De Gomez Dumm, I.N.T.; Brenner, R.R. Oxidative desaturation of alphalinolenic, linoleic, and stearic acids by human liver microsomes. Lipids 1975, 10, 315–317.
22. Emken, E.A.; Adlof, R.O.; Rakoff, H.; Rohwedder, W.K. Metabolism of deuterium-labeled linolenic, linoleic, oleic, stearic and palmitic acid in human subjects. In Synthesis and Application of Isotopically Labeled Compounds 1988; Baillie, T.A., Jones, J.R., Eds.; Elsevier Science Publishers: Amsterdam, The Netherlands, 1989; pp. 713–716.
23. Hague, T.A.; Christoffersen, B.O. Effect of dietary fats on arachidonic acid and eicosapentaenoic acid biosynthesis and conversion to C22 fatty acids in isolated liver cells. Biochim. Biophys. Acta 1984, 796, 205–217.
24. Hague, T.A.; Christoffersen, B.O. Evidence for peroxisomal retroconversion of adrenic acid (22, 4n6) and docosahexaenoic acid (22, 6n3) in isolated liver cells. Biochim. Biophys. Acta 1986, 875, 165–173.
25. Indu, M.; Ghafoorunissa, P. N-3 fatty acids in Indian diets—Comparison of the effects of precursor (alpha-linolenic acid) vs. product (long chain n-3 polyunsaturated fatty acids). Nutr. Res. 1992, 12, 569–582.
26. Ameur, A.; Enroth, S.; Johansson, A.; Zaboli, G.; Igl, W.; Johansson, A.C.; Rivas, M.A.; Daly, M.J.; Schmitz, G.; Hicks, A.A. et al. Genetic Adaptation of Fatty-Acid Metabolism: A Human-Specific Haplotype Increasing the Biosynthesis of Long-Chain ω-3 and ω-6 Fatty Acids. Am. J. Hum. Genet. 2012, 90, 809–820.
27. Sergeant, S.; Hugenschmidt, C.E.; Rudock, M.E.; Ziegler, J.T.; Ivester, P.; Ainsworth, H.C.; Vaidya, D.; Case, L.D.; Langefeld, C.D.; Freedman, B.I. et al. Differences in arachidonic acid levels and fatty acid desaturase (FADS) gene variants in African Americans and European Americans with diabetes or the metabolic syndrome. Br. J. Nutr. 2012,107, 547–555.
28. Mathias, R.A.; Sergeant, S.; Ruczinski, I.; Torgerson, D.G.; Hugenschmidt, C.E.; Kubala, M.; Vaidya, D.; Suktitipat, B.; Ziegler, J.T.; Ivester, P. et al. The impact of FADS genetic variants on ω6 polyunsaturated fatty acid metabolism in African Americans. BMC Genet. 2011, 12, 50.
29. Carlson, S.E.; Rhodes, P.G.; Ferguson, M.G. Docosahexaenoic acid status of preterm infants at birth and following feeding with human milk or formula. Am. J. Clin. Nutr. 1986, 44, 798–804.
30. Singer, P.; Jaeger, W.; Voigt, S.; Theil, H. Defective desaturation and elongation of n-6 and n-3 fatty acids in hypertensive patients. Prostaglandins Leukot. Med. 1984, 15, 159–165.
31. Honigmann, G.; Schimke, E.; Beitz, J.; Mest, H.J.; Schliack, V. Influence of a diet rich in linolenic acid on lipids, thrombocyte aggregation and prostaglandins in type I (insulin-dependent) diabetes. Diabetologia 1982, 23, 175.
32. Simopoulos, A.P. Essential fatty acids in health and chronic disease. Am. J. Clin. Nutr. 1999, 70 (Suppl.), 560S–569S.
33. Simopoulos, A.P. The importance of the ω-6/ω-3 Balance in Health and Disease: Evolutionary Aspects of Diet. In Healthy Agriculture, Healthy Nutrition, Healthy People; Simopoulos, A.P., Ed.; Karger: Basel, Switzerland, 2011; Volume 102, pp. 10–21.
34. Eaton, S.B.; Konner, M. Paleolithic nutrition. A consideration of its nature and current implications. N. Engl. J. Med.1985, 312, 283–289.
35. Simopoulos, A.P. Overview of evolutionary aspects of ω3 fatty acids in the diet. In The Return of ω-3 Fatty Acids into the Food Supply. I. Land-Based Animal Food Products and Their Health Effects; Simopoulos, A.P., Ed.; Karger: Basel, Switzerland, 1998; Volume 83, pp. 1–11.
36. Crawford, M.A. Fatty acid ratios in free-living and domestic animals. Lancet 1968, 1, 1329–1333.
37. Wo, C.K.; Draper, H.H. Vitamin E status of Alaskan Eskimos. Am. J. Clin. Nutr. 1975, 28, 808–813.
38. Crawford, M.A.; Gale, M.M.; Woodford, M.H. Linoleic acid and linoleic acid elongation products in muscle tissue of Syncerus caffer and other ruminant species. Biochem. J. 1969, 115, 25–27.
39. Raper, N.R.; Cronin, F.J.; Exler, J. ω-3 fatty acid content of the US food supply. J. Am. College Nutr. 1992, 11, 304.
40. Simopoulos, A.P.; Salem, N., Jr. Purslane: A terrestrial source of ω-3 fatty acids. N. Engl. J. Med. 1986, 315, 833.
41. Van Vliet, T.; Katan, M.B. Lower ratio of n-3 to n-6 fatty acids in cultured than in wild fish. Am. J. Clin. Nutr. 1990, 51, l–2.
42. Simopoulos, A.P.; Salem, N., Jr. Egg yolk as a source of long-chain polyunsaturated fatty acids in infant feeding. Am. J. Clin. Nutr. 1992, 55, 411–414.
43. Simopoulos, A.P.; Norman, H.A.; Gillapsy, J.E.; Duke, J.A. Common purslane: A source of ω-3 fatty acids and antioxidants. J. Am. Coll. Nutr. 1992, 11, 374–382.
44. Simopoulos, A.P. Nutrition and Fitness. JAMA 1989, 261, 2862–2863.
45. Simopoulos, A.P.; Salem, N., Jr. N-3 Fatty acid in eggs from range-fed Greek chickens. N. Engl. J. Med. 1989, 321, 1412.
46. Simopoulos, A.P.; Norman, H.A.; Gillapsy, J.E. Purlsane in human nutrition and its potential for world agriculture. In Plants in Human Nutrition; Simopoulos, A.P., Ed.; Karger: Basel, Switzerland, 1995; Volume 77, pp. 47–74.
47. Simopoulos, A.P. Trans-fatty acids. In Handbook of Lipids in Human Nutrition; Spiller, G.A., Ed.; CRC Press: Boca Raton, FL, USA, 1995; pp. 91–99.
48. Dupont, J.; White, P.J.; Feldman, E.B. Saturated and hydrogenated fats in food in relation to health. J. Am. Coll. Nutr.1991, 10, 577–592.
49. Litin, L.; Sacks, F. Trans-fatty acid content of common foods. N. Engl. J. Med. 1993, 329, 1969–1970.
50. Guil, J.L.; Torija, M.E.; Gimenez, J.J.; Rodríguez, I. Identification of fatty acids in edible wild plants by gas chromatography. J. Chromatogr. A 1996, 719, 229–235.
51. Cordain, L.; Martin, C.; Florant, G.; Watkins, B.A. The fatty acid composition of muscle, brain, marrow and adipose tissue in elk: Evolutionary implications for human dietary lipid requirements. World Rev. Nutr. Diet. 1998, 83, 225–226.
52. Sinclair, A.J.; Slattery, W.J.; O’Dea, K. The analysis of polyunsaturated fatty acids in meat by capillary gas-liquid chromatography. J. Food Sci. Agri. 1982, 33, 771–776.
53. Simopoulos, A.P. The role of fatty acids in gene expression: Health implications. Ann. Nutr. Metab. 1996, 40, 303–311.
54. Elton, S. Environments, Adaptation, and Evolutionary Medicine: Should We Be Eating a Stone Age Diet? In Medicine and Evolution: Current Applications, Future Prospects; Elton, S., O’Higgins, P., Eds.; CRC Press: Boca Raton, FL, USA, 2008; pp. 9–34.
55. Eaton, S.B.; Konner, M.; Shostak, M. Stone agers in the fast lane: Chronic degenerative diseases in evolutionary perspective. Am. J. Med. 1988, 84, 739–749.
56. Kuipers, R.S.; Luxwolda, M.F.; Dijck-Brouwer, D.A.; Eaton, S.B.; Crawford, M.A.; Cordain, L.; Muskiet, F.A. Estimated macronutrient and fatty acid intakes from an East African Paleolithic diet. Br. J. Nutr. 2010, 104, 1666–1687.
57. Guil-Guerrero, J.L.; Tikhonov, A.; Rodríguez-García, I.; Protopopov, A.; Grigoriev, S.; Ramos-Bueno, R.P. The fat from frozen mammals reveals sources of essential fatty acids suitable for Palaeolithic and Neolithic humans. PLoS ONE 2014, 9, e84480.
58. Eaton, S.B.; Eaton, S.B., III; Sinclair, A.J.; Cordain, L.; Mann, N.J. Dietary intake of long-chain polyunsaturated fatty acids during the Paleolithic. In The Return of w-3 Fatty Acids into the Food Supply. I. Land-Based Animal Food Products and Their Health Effects; Simopoulos, A.P., Ed.; Karger: Basel, Switzerland, 1998; Volume 83, pp. 12–23.
59. Simopoulos, A.P. Importance of the ratio of ω-6/ω-3 essential fatty acids: Evolutionary aspects. In Omega-6/Omega-3 Essential Fatty Acid Ratio: The Scientific Evidence; Simopoulos, A.P., Cleland, L.G., Eds.; Karger: Basel, Switzerland, 2003; Volume 92, pp. 1–22.
60. Amri, E.Z.; Ailhaud, G.; Grimaldi, P.A. Fatty acids as signal transducing molecules: Involvement in the differentiation of preadipose to adipose cells. J. Lipid Res. 1994, 35, 930–937.
61. Jump, D.B.; Clarke, S.D.; Thelen, A.; Liimatta, M. Coordinate regulation of glycolytic and lipogenic gene expression by polyunsaturated fatty acids. J. Lipid Res. 1994, 35, 1076–1084.
62. Clarke, S.D.; Jump, D. Polyunsaturated fatty acids regulate lipogenic and peroxisomal gene expression by independent mechanisms. Prostaglandins Leukot. Essent. Fatty Acids 1997, 57, 65–69.
63. Schwinkendorf, D.R.; Tsatsos, N.G.; Gosnell, B.A.; Mashek, D.G. Effects of central administration of distinct fatty acids on hypothalamic neuropeptide expression and energy metabolism. Int. J. Obes. 2011, 35, 336–344.
64. James, M.J.; Gibson, R.A.; Cleland, L.G. Dietary polyunsaturated fatty acids and inflammatory mediator production.Am. J. Clin. Nutr. 2000, 71, 343S–348S.
65. Gaillard, D.; Negrel, R.; Lagarde, M.; Ailhaud, G. Requirement and role of arachidonic acid in the differentiation of preadipose cells. Biochem. J. 1989, 257, 389–397.
66. Corey, E.J.; Shih, C.; Cashman, J.R. Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc. Natl. Acad. Sci. USA 1983, 80, 3581–3584.
67. Massaro, M.; Habib, A.; Lubrano, L.; Del Turco, S.; Lazzerini, G.; Bourcier, T.; Weksler, B.B.; De Caterina, R. The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc. Natl. Acad. Sci. USA 2006, 103, 15184–15189.
68. Ringbom, T.; Huss, U.; Stenholm, A.; Flock, S.; Skattebol, L.; Perera, P.; Bohlin, L. Cox-2 inhibitory effects of naturally occurring and modified fatty acids. J. Nat. Prod. 2001, 64, 745–749.
69. Mirnikjoo, B.; Brown, S.E.; Kim, H.F.; Marangell, L.B.; Sweatt, J.D.; Weeber, E.J. Protein kinase inhibition by omega-3 fatty acids. J. Biol. Chem. 2001, 276, 10888–10896.
70. Hennig, B.; Watkins, B.A. Linoleic acid and linolenic acid: Effect on permeability properties of cultured endothelial cell monolayers. Am. J. Clin. Nutr. 1989, 49, 301–305.
71. Ukropec, J.; Reseland, J.E.; Gasperikova, D.; Demcakova, E.; Madsen, L.; Berge, R.K.; Rustan, A.C.; Klimes, I.; Drevon, C.A.; Sebokova, E. The hypotriglyceridemic effect of dietary n-3 FA is associated with increased beta-oxidation and reduced leptin expression. Lipids 2003, 38, 1023–1029.
72. Lepperdinger, G. Inflammation and mesenchymal stem cell aging. Curr. Opin. Immunol. 2011, 23, 518–524.
73. Massiera, F.; Barbry, P.; Guesnet, P.; Joly, A.; Luquet, S.; Moreilhon-Brest, C.; Mohsen-Kanson, T.; Amri, E.Z.; Ailhaud, G. A Western-like fat diet is sufficient to induce a gradual enhancement in fat mass over generations. J. Lipid Res.2010, 51, 2352–2561.
74. Pisani, D.F.; Amri, E.Z.; Ailhaud, G. Disequilibrium of polyunsaturated fatty acids status and its dual effect in modulating adipose tissue development and functions. OCL 2015, 22, D405.
75. Baillie, R.A.; Takada, R.; Nakamura, M.; Clarke, S.D. Coordinate induction of peroxisomal acyl-CoA oxidase and UCP-3 by dietary fish oil: A mechanism for decreased body fat deposition. Prostaglandins Leukot. Essent. Fatty Acids1999, 60, 351–356.
76. Phillips, C.M.; Goumidi, L.; Bertrais, S.; Field, M.R.; Ordovas, J.M.; Cupples, L.A.; Defoort, C.; Lovegrove, J.A.; Drevon, C.A.; Blaak, E.E. et al. Leptin receptor polymorphisms interact with polyunsaturated fatty acids to augment risk of insulin resistance and metabolic syndrome in adults. J. Nutr. 2010, 140, 238–244.
77. Cheng, L.; Yu, Y.; Zhang, Q.; Szabo, A.; Wang, H.; Huang, X.F. Arachidonic acid impairs hypothalamic leptin signaling and hepatic energy homeostasis in mice. Mol. Cell. Endocrinol. 2015, 5, 412, 12–18.
78. Perez-Matute, P.; Perez-Echarri, N.; Martinez, J.A.; Marti, A.; Moreno-Aliaga, M.J. Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: Role of apoptosis, adiponectin and tumour necrosis factor-alpha. Br. J. Nutr. 2007, 97, 389–398.
79. Hassanali, Z.; Ametaj, B.N.; Field, C.J.; Proctor, S.D.; Vine, D.F. Dietary supplementation of n-3 PUFA reduces weight gain and improves postprandial lipaemia and the associated inflammatory response in the obese JCR: LA-cp rat. Diabetes Obes. Metab. 2010, 12, 139–147.
80. Alvheim, A.R.; Torstensen, B.E.; Lin, Y.H.; Lillefosse, H.H.; Lock, E.J.; Madsen, L.; Frøyland, L.; Hibbeln, J.R.; Malde, M.K. Dietary linoleic acid elevates the endocannabinoids 2-AG and anandamide and promotes weight gain in mice fed a low fat diet. Lipids 2014, 49, 59–69.
81. Banni, S.; Di Marzo, V. Effect of dietary fat on endocannabinoids and related mediators: consequences on energy homeostasis, inflammation and mood. Mol. Nutr. Food Res. 2010, 54, 82–92.
82. Matias, I.; Di Marzo, V. Endocannabinoids and the control of energy balance. Trends Endocrinol. Metab. 2007, 18, 27–37.
83. Buckley, J.D.; Howe, P.R. Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids. Obes. Rev. 2009, 10, 648–659.
84. Hainault, I.; Carolotti, M.; Hajduch, E.; Guichard, C.; Lavau, M. Fish oil in a high lard diet prevents obesity, hyperlipemia, and adipocyte insulin resistance in rats. Ann. N. Y. Acad. Sci. 1993, 683, 98–101.
85. Belzung, F.; Raclot, T.; Groscolas, R. Fish oil n-3 fatty acids selectively limit the hypertrophy of abdominal fat depots in growing rats fed high-fat diets. Am. J. Physiol. 1993, 264, R1111–R1118.
86. Parrish, C.C.; Pathy, D.A.; Angel, A. Dietary fish oils limit adipose tissue hypertrophy in rats. Metabolism 1990, 39, 217–219.
87. Ruzickova, J.; Rossmeisl, M.; Prazak, T.; Flachs, P.; Sponarova, J.; Veck, M.; Tvrzicka, E.; Bryhn, M.; Kopecky, J. Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue. Lipids 2004, 39, 1177–1185.
88. Nuernberg, K.; Breier, B.H.; Jayasinghe, S.N.; Bergmann, H.; Thompson, N.; Nuernberg, G.; Dannenberger, D.; Schneider, F.; Renne, U.; Langhammer, M. et al. Metabolic responses to high-fat diets rich in n-3 or n-6 long-chain polyunsaturated fatty acids in mice selected for either high body weight or leanness explain different health outcomes. Nutr. Metab. 2011, 8, 56.
89. Kang, J.X.; Wang, J.; Wu, L.; Kang, Z.B. Transgenic mice: Fat-1 mice convert n-6 to n-3 fatty acids. Nature 2004, 427, 504.
90. Jump, D.B.; Clarke, S.D. Regulation of gene expression by dietary fat. Annu. Rev. Nutr. 1999, 19, 63–90.
91. Jump, D.B. Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr. Opin. Lipidol. 2002, 13, 155–164.
92. Suzukawa, M.; Abbey, M.; Howe, P.R.; Nestel, P.J. Effects of fish oil fatty acids on low-density lipoprotein size, oxidizability, and uptake by macrophages. J. Lipid Res. 1995, 36, 473–484.
93. Li, J.; Li, F.R.; Wei, D.; Jia, W.; Kang, J.X.; Stefanovic-Racic, M.; Dai, Y.; Zhao, A.Z. Endogenous ω-3 Polyunsaturated Fatty Acid Production Confers Resistance to Obesity, Dyslipidemia, and Diabetes in Mice. Mol. Endocrinol. 2014, 28, 1316–1328.
94. Kabir, M.; Skurnik, G.; Naour, N.; Pechtner, V.; Meugnier, E.; Rome, S.; Quignard-Boulangé, A.; Vidal, H.; Slama, G.; Clément, K. et al. Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: A randomized controlled study. Am. J. Clin. Nutr. 2007, 86, 1670–1679.
95. Thorsdottir, I.; Tomasson, H.; Gunnarsdottir, I.; Gisladottir, E.; Kiely, M.; Parra, M.D.; Bandarra, N.M.; Schaafsma, G.; Martinéz, J.A. Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content. Int. J. Obes.2007, 31, 1560–1566.
96. Parra, D.; Ramel, A.; Bandarra, N.; Kiely, M.; Martinez, J.A.; Thorsdottir, I. A diet rich in long chain omega-3 fatty acids modulates satiety in overweight and obese volunteers during weight loss. Appetite 2008, 51, 676–680.
97. Krebs, J.D.; Browning, L.M.; McLean, N.K.; Rothwell, J.L.; Mishra, G.D.; Moore, C.S.; Jebb, S.A. Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. Int. J. Obes. 2006, 30, 1535–1544.
98. Kunesova, M.; Braunerová, R.; Hlavatý, P.; Tvrzická, E.; Stanková, B.; Skrha, J.; Hilgertová, J.; Hill, M.; Kopecký, J.; Wagenknecht, M. et al. The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. Physiol. Res.2006, 55, 63–72.
99. Simopoulos, A.P. Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk. Exp. Biol. Med. 2010, 235, 785–795.
100. Wang, L.; Manson, J.E.; Rautiainen, S.; Gaziano, J.M.; Buring, J.E.; Tsai, M.Y.; Sesso, H.D. A prospective study of erythrocyte polyunsaturated fatty acid, weight gain, and risk of becoming overweight or obese in middle-aged and older women. Eur. J. Nutr. 2015.
101. Claussnitzer, M.; Dankel, S.N.; Kim, K.H.; Quon, G.; Meuleman, W.; Haugen, C.; Glunk, V.; Sousa, I.S.; Beaudry, J.L.; Puviindran, V. et al. FTO Obesity Variant Circuitry and Adipocyte Browning in Humans. N. Engl. J. Med. 2015, 373, 895–907.
102. Savva, S.C.; Chadjigeorgiou, C.; Hatzis, C.; Kyriakakis, M.; Tsimbinos, G.; Tornaritis, M.; Kafatos, A. Association of adipose tissue arachidonic acid content with BMI and overweight status in children from Cyprus and Crete. Br. J. Nutr. 2004, 91, 643–649.
103. Jensen, C.L.; Prager, T.C.; Fraley, J.K.; Chen, H.; Anderson, R.E.; Heird, W.C. Effect of dietary linoleic/alpha-linolenic acid ratio on growth and visual function of term infants. J. Pediatr. 1997, 131, 200–209.
104. Ahima, R.S.; Antwi, D.A. Brain regulation of appetite and satiety. Endocrinol. Metab. Clin. N. Am. 2008, 37, 811–823.
105. Artmann, A.; Petersen, G.; Hellgren, L.; Boberg, J.; Skonberg, C.; Nellemann, C.; Hansen, S.H.; Hansen, H.S. Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine.Biochim. Biophys. Acta 2008, 1781, 200–212.
106. Yoshida, R.; Ohkuri, T.; Jyotaki, M.; Yasuo, T.; Horio, N.; Yasumatsu, K.; Sanematsu, K.; Shigemura, N.; Yamamoto, T.; Margolskee, R.F. et al. Endocannabinoids selectively enhance sweet taste. Proc. Natl. Acad. Sci. USA 2010, 107, 935–939.
107. Van Gaal, L.; Pi-Sunyer, X.; Despres, J.P.; McCarthy, C.; Scheen, A. Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: Pooled 1-year data from the Rimonabant in Obesity (RIO) program. Diabetes Care 2008, 31, S229–S240.
108. Christensen, R.; Kristensen, P.K.; Bartels, E.M.; Bliddal, H.; Astrup, A. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 2007, 370, 1706–1713.